Skip to main content
Fig. 1 | EJNMMI Research

Fig. 1

From: Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

Fig. 1

Anti-tumor effect of 177Lu-octreotate with priming on GOT1 in nude mice. The mean relative tumor volume versus time after last injection for mice i.v.-injected with 5 + 10 MBq 177Lu-octreotate or NaCl and killed at 1, 3, 7 or 41 days after the last injection. The mean absorbed dose to tumors processed for transcriptional analysis is indicated by the corresponding data point. Vertical error bars indicate SEM, and horizontal error bars indicate range. The figure is based on the tumor volume and biodistribution data analyzed in these animals in Dalmo et al. [12]. Green arrow indicates the time for treatment start. Asterisk indicates statistically significant difference versus controls (t test, p < 0.05)

Back to article page